Digital Vision and Neurolens Collaborate to Increase Prism Specificity
With the aim of providing a new standard of care when addressing the growing prevalence of eye misalignment, Neurolens and Digital Vision (DVI) have expanded the prism field from 1/8th prism diopter to 1/100th prism diopter for all Neurolens designs. This enhancement will cross all DVI platforms, including VISION Lab Management System, RxWizard, Web-based RxWizard, and the SEER mobile app.
“This development is yet another exciting signal that the vision industry recognizes the important role that prism will play in the future of eye care,” Pierre Bertrand, Chief Executive Officer of Neurolens, said in a company news release. “At least two out of three patients experience the symptoms of eye misalignment, and this number is growing. Neurolenses provide proven relief for these patients, and we are exicted that DVI recognizes the opportunity to drive even more positive patient outcomes.”
This expanded prism range will allow Neurolens providers to take advantage of the accurate measurements from the Neurolens Measurement Device, Gen 2 (NMD2) and prescribe precise prism measurements for their patients. Neurolens designs are currently the only lens designs that can be ordered and manufactured to the 1/100th prism diopter on DVI platforms, according to Neurolens.
“We are learning more every day about how small amounts of prism can create tremendous symptom relief for patients,” said Vivek Labhishetty, BSc Optometry, MSc, PhD, Director of Clinical Research for Neurolens. “This creates an imperative to ensure prism measurements can be entered with a high degree of specificity to maximize the number of patients that can be helped by this technology.”